Cargando…

Systemic Therapy De-Escalation in Early-Stage Triple-Negative Breast Cancer: Dawn of a New Era?

SIMPLE SUMMARY: Triple-negative breast cancer is a life-threatening disease, even when identified at early stages. Recent advances have allowed the improvement of life expectancy via a personalized approach with the addition of newer chemotherapies, immunotherapies, and targeted therapies, but at th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, Ravi Kumar, Roy, Arya Mariam, Gupta, Ashish, Takabe, Kazuaki, Dhakal, Ajay, Opyrchal, Mateusz, Kalinski, Pawel, Gandhi, Shipra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025008/ https://www.ncbi.nlm.nih.gov/pubmed/35454764 http://dx.doi.org/10.3390/cancers14081856

Ejemplares similares

Cytotoxic T-lymphocyte infiltration and chemokine predict long-term patient survival independently of tumor mutational burden in triple-negative breast cancer
por: Katsuta, Eriko, et al.
Publicado: (2021)

47982 Reversing the resistance to chemotherapy in White and Black patients with triple negative breast cancer (TNBC).
por: Gandhi, Shipra, et al.
Publicado: (2021)

Left sided breast cancer is associated with aggressive biology and worse outcomes than right sided breast cancer
por: Abdou, Yara, et al.
Publicado: (2022)

Impact of Environmental Temperature on the Pathological Complete Response and Survival Outcomes of Breast Cancer: A NCDB and SEER study
por: Gupta, Ashish, et al.
Publicado: (2023)

Novel Biomarkers to Guide Immunotherapy De-Escalation in the Neoadjuvant Setting in Triple-Negative Breast Cancer
por: Gandhi, Shipra
Publicado: (2023)

Enhanced Thermogenesis in Triple-Negative Breast Cancer Is Associated with Pro-Tumor Immune Microenvironment
por: Gandhi, Shipra, et al.
Publicado: (2021)

Contribution of Immune Cells to Glucocorticoid Receptor Expression in Breast Cancer
por: Gandhi, Shipra, et al.
Publicado: (2020)

High MYC mRNA Expression Is More Clinically Relevant than MYC DNA Amplification in Triple-Negative Breast Cancer
por: Katsuta, Eriko, et al.
Publicado: (2019)

Mechano-Sensing Channel PIEZO2 Enhances Invasive Phenotype in Triple-Negative Breast Cancer
por: Katsuta, Eriko, et al.
Publicado: (2022)

NR2F1, a Tumor Dormancy Marker, Is Expressed Predominantly in Cancer-Associated Fibroblasts and Is Associated with Suppressed Breast Cancer Cell Proliferation
por: Wu, Rongrong, et al.
Publicado: (2022)

A new era dawns on sickle cell disease in India
por: Kishore, R. R., et al.
Publicado: (2023)

Dawn of a New Era for Membrane Protein Design
por: Sowlati-Hashjin, Shahin, et al.
Publicado: (2022)

ERAS – The dawn of a new era!
por: Gopinath, Ramachandran, et al.
Publicado: (2019)

Plasmacytoid Dendritic Cell (pDC) Infiltration Correlate with Tumor Infiltrating Lymphocytes, Cancer Immunity, and Better Survival in Triple Negative Breast Cancer (TNBC) More Strongly than Conventional Dendritic Cell (cDC)
por: Oshi, Masanori, et al.
Publicado: (2020)

Weekly paclitaxel in escalating doses in a patient with anthracycline-resistant, triple-negative, metastatic breast cancer with severe liver dysfunction
por: Gupta, Ajay
Publicado: (2012)

The dawn of a new era
Publicado: (2017)

The Dawn of the Post-Naturalness Era
por: Giudice, Gian Francesco
Publicado: (2019)

Primary and secondary breast angiosarcoma: single center report and a meta-analysis
por: Abdou, Yara, et al.
Publicado: (2019)

Neoadjuvant Chemotherapy for Breast Cancer: Past, Present, and Future
por: Asaoka, Mariko, et al.
Publicado: (2020)

Quarkonium physics at the dawn of the LHC era
Publicado: (2008)

New era dawns at home of the internet
Publicado: (2008)

Experimental Achievements at the Dawn of LHC Era
por: Šafarík,Karel
Publicado: (2012)

Heavy Ion Collisions at the dawn of the LHC era
por: Takahashi, J.
Publicado: (2011)

Proteomics in rheumatology: the dawn of a new era
por: Vanarsa, Kamala, et al.
Publicado: (2010)

Pathogenesis of Dengue: Dawn of a New Era
por: Halstead, Scott B.
Publicado: (2015)

The dawn of a new era in treating T-PLL
por: Schrader, Alexandra, et al.
Publicado: (2019)

Dawn of a new era of diabeto‐oncology
por: Noto, Hiroshi
Publicado: (2020)

Pustular Psoriasis: The Dawn of a New Era
por: BACHELEZ, Hervé
Publicado: (2020)

Gastroenterology in the Metaverse: The dawn of a new era?
por: Zhang, Chi, et al.
Publicado: (2022)

The dawn of a new era in surgery for lymphedema
por: Hashikawa, Kazunobu, et al.
Publicado: (2023)

Outcome of Everolimus-Based Therapy in Hormone-Receptor-Positive Metastatic Breast Cancer Patients After Progression on Palbociclib
por: Dhakal, Ajay, et al.
Publicado: (2020)

De-Escalating the Management of In Situ and Invasive Breast Cancer
por: Angarita, Fernando A., et al.
Publicado: (2022)

The Dawning Era of Comprehensive Transcriptome Analysis in Cellular Microbiology
por: Aikawa, Chihiro, et al.
Publicado: (2010)

The dawn of a new era in cell signalling research
por: Feller, Stephan M
Publicado: (2010)

SMYD proteins in immunity: dawning of a new era
por: Doughan, Maysaa, et al.
Publicado: (2016)

Wake-up stroke: Dawn of a new era
por: Malhotra, Konark, et al.
Publicado: (2016)

JGH Open: The dawn of a new era in publishing!
por: Goh, KL
Publicado: (2017)

Oropharyngeal cancer: the dawn of the RNA era in precision medicine
por: Rampias, Theodoros
Publicado: (2020)

Community health workers at the dawn of a new era
por: Zulu, Joseph M., et al.
Publicado: (2021)

Genomics in Cushing’s Disease: The Dawn of a New Era
por: Reincke, Martin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jn3dva4kpfp0v7oqjtlk2aj9g2